AI Bias Analysis
4 models · Takes ~15 seconds
Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make that happen.
Source
Stat News
Opens original article in a new tab
“The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.
A Supreme Court ruling this week on gender and sexuality “conversion therapy” could narrow the authority of state medical boards over care involving speech
CMS is scaling back the number of measures it uses to grade health insurers.
(MedPage Today) -- DENVER -- Biological agents targeting interleukin-4 receptor alpha (IL-4Rα) in atopic dermatitis (AD) achieved rapid and substantial improvement in up to three-fourths of patients, according to randomized trials from China...